Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Certain hormone treatments can improve acne and related conditions in women.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Healthy women tend to lose more hair in July and April, and the least in February.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Most skin changes during pregnancy go away after giving birth.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Finasteride reduces hair growth and is safe for women with excessive hair.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.